Oral Carbapenem Wins FDA Approval for cUTIs

• by Kathryn Wighton

• June 17, 2026

Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Nangarhar, Afghanistan

• by Shah Agha Salehi, Sant Muangnoicharoen, Natthida Sriboonvorakul, Janjira Thaipadungpanit, Jittima Dhitavat, Udomsak Silachamroon, Wiwat Chancharoenthana

• February 5, 2026

Sugar may worsen antibiotic-induced gut dysbiosis

The effect was most apparent with added sugars and formulated nutritional drinks, including sports drinks and nutritional shakes.

• by Andrea Surnit

• October 7, 2026

• 5 min

DOOR framework shows similar outcomes in skin infection trials

“Using DOOR can provide clinicians and patients with a better understanding of the benefits and risks of new anti-infectives being studied to treat skin infections.” 

• by Matthew Solan

• August 24, 2026

• 7 min